elegslab

elegslab accelerates drug discovery with AI-automated C. elegans platforms—a next-generation NAMs solution.

elegslab is a business in global overseas acceleration & learning (goal) based in Silicon Valley, California.

Profile

elegslab (엘렉스랩) is a Korea-based biotech and AI company developing an end-to-end drug discovery platform that integrates automated lab devices, biochips, and AI-driven analytics. The company enables high-throughput in vivo screening and predictive modeling of drug efficacy and toxicity, helping pharmaceutical, biotech, and related industries accelerate R&D with standardized, data-driven insights.

Its activity falls under global overseas acceleration & learning (goal); the profile below is assembled from public directory data.

Silicon Valley, California is where the company is located.

The company is listed at the Plug and Play portfolio startup stage of development.

Website: elegslab.com